TWD 43.4
(-9.58%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 170.56 Million TWD | 81.29% |
2022 | 94.08 Million TWD | 110.53% |
2021 | 44.68 Million TWD | -59.25% |
2020 | 109.66 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 135.52 Million TWD | -20.54% |
2023 FY | 170.56 Million TWD | 81.29% |
2023 Q4 | 170.56 Million TWD | -4.79% |
2023 Q2 | 179.14 Million TWD | 90.4% |
2022 Q4 | 94.08 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2338.705% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 70.768% |
Level Biotechnology Inc. | 273.2 Million TWD | 37.569% |
Sagittarius Life Science Corp | 137.82 Million TWD | -23.754% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | 13.626% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 87.155% |
GlycoNex Incorporation | 276.39 Million TWD | 38.291% |
VBI | 21.25 Million TWD | -702.612% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 45.63% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 66.859% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -703.557% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 53.693% |
Visgeneer Inc. | 185.6 Million TWD | 8.104% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 87.11% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 76.73% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -42.302% |
Neith Corporation | 17.43 Million TWD | -878.392% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 92.406% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2477.259% |
Enimmune corporation | 173.46 Million TWD | 1.672% |
TaiRx, Inc. | 60.62 Million TWD | -181.341% |
CHO Pharma, Inc. | 110.83 Million TWD | -53.893% |
EirGenix Inc. | 1.14 Billion TWD | 85.105% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -52.314% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 66.715% |
Lin BioScience, Inc. | 167.73 Million TWD | -1.689% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -82.004% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -170.589% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -36.747% |
Lukas Biomedical Inc. | 161.05 Million TWD | -5.901% |
RBC Bioscience Corporation | 513.08 Million TWD | 66.757% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -304.58% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -633.447% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -536.121% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 82.5% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2039.526% |
NaviFUS Corp. | 53.4 Million TWD | -219.4% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 64.576% |
Sinew Pharma Inc. | 39.71 Million TWD | -329.478% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -193.877% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 53.203% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 25.091% |
AP Biosciences Inc | 106.65 Million TWD | -59.928% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 95.168% |
3D Global Biotech Inc. | 30.68 Million TWD | -455.924% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | 12.974% |
Intech Biopharm Corporation | 1.54 Billion TWD | 88.948% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 80.314% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1738.756% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -205.597% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 26.784% |
TCI GENE Inc. | 155.54 Million TWD | -9.653% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -568.665% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -269.384% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 48.073% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -162.862% |
PharmaEngine, Inc. | 91 Million TWD | -87.42% |
Savior Lifetec Corporation | 457.95 Million TWD | 62.756% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -53.743% |
OBI Pharma, Inc. | 650.44 Million TWD | 73.778% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 56.357% |
Acepodia, Inc. | 384.47 Million TWD | 55.637% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -99.365% |